{
 "drug": "Dopamine Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "11/06/2017",
 "dayN": 3214,
 "cat": "Cardiovascular",
 "companies": [
  "Baxter Healthcare",
  "Hospira, Inc., a Pfizer Company",
  "Hikma Pharmaceuticals USA, Inc."
 ],
 "reasons": [
  "Demand increase for the drug",
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1005-02",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA019615"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE AND DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1005",
     "0338-1007",
     "0338-1009"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743869",
     "1743871",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"
    ],
    "spl_set_id": [
     "cb97d4a0-89ed-407c-a763-209386b6f75c"
    ],
    "package_ndc": [
     "0338-1005-02",
     "0338-1005-03",
     "0338-1007-02",
     "0338-1007-03",
     "0338-1009-02"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "New",
   "initial_posting_date": "08/27/2025",
   "package_ndc": "0409-7809-24",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA018826"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7809",
     "0409-7810",
     "0409-0042",
     "0409-1858"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "188ce800-ff3a-4b22-9a95-2273c3bc99ae"
    ],
    "spl_set_id": [
     "08f23f6e-150d-45ea-098e-f2edf64c21a1"
    ],
    "package_ndc": [
     "0409-7809-11",
     "0409-7809-22",
     "0409-7809-31",
     "0409-7809-24",
     "0409-7810-11",
     "0409-7810-22",
     "0409-0042-01",
     "0409-0042-12",
     "0409-1858-01",
     "0409-1858-12"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/27/2025",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (NDC 0409-7809-24)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-5820-01",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018132"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-5820",
     "0409-9104"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1743938",
     "1743941"
    ],
    "spl_id": [
     "7a125e39-1ecb-4c76-931a-efc9b5921d1c"
    ],
    "spl_set_id": [
     "1f306ad2-3606-4525-5a8a-ce78f426c1a2"
    ],
    "package_ndc": [
     "0409-5820-11",
     "0409-5820-01",
     "0409-9104-21",
     "0409-9104-20"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0143-9254-25",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Additional lots will be available in the September 2026 timeframe.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA207707"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9254",
     "0143-9252",
     "0143-9253",
     "0143-9255"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1743938",
     "1743941",
     "1743950",
     "1743953"
    ],
    "spl_id": [
     "67349236-e8e3-45ec-a76d-2a0a150d8d59"
    ],
    "spl_set_id": [
     "0e499952-46c7-4172-8c70-186312e240a3"
    ],
    "package_ndc": [
     "0143-9252-01",
     "0143-9252-25",
     "0143-9253-01",
     "0143-9253-25",
     "0143-9254-01",
     "0143-9254-25",
     "0143-9255-01",
     "0143-9255-25"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1005-03",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA019615"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE AND DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1005",
     "0338-1007",
     "0338-1009"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743869",
     "1743871",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"
    ],
    "spl_set_id": [
     "cb97d4a0-89ed-407c-a763-209386b6f75c"
    ],
    "package_ndc": [
     "0338-1005-02",
     "0338-1005-03",
     "0338-1007-02",
     "0338-1007-03",
     "0338-1009-02"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1007-03",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA019615"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE AND DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1007",
     "0338-1005",
     "0338-1009"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743869",
     "1743871",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"
    ],
    "spl_set_id": [
     "cb97d4a0-89ed-407c-a763-209386b6f75c"
    ],
    "package_ndc": [
     "0338-1005-02",
     "0338-1005-03",
     "0338-1007-02",
     "0338-1007-03",
     "0338-1009-02"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-9104-20",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018132"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-9104",
     "0409-5820"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1743938",
     "1743941"
    ],
    "spl_id": [
     "7a125e39-1ecb-4c76-931a-efc9b5921d1c"
    ],
    "spl_set_id": [
     "1f306ad2-3606-4525-5a8a-ce78f426c1a2"
    ],
    "package_ndc": [
     "0409-5820-11",
     "0409-5820-01",
     "0409-9104-21",
     "0409-9104-20"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0143-9252-25",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Product temporarily on backorder.  Additional lots will be available in the February 2027 timeframe.",
   "openfda": {
    "application_number": [
     "ANDA207707"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9252",
     "0143-9253",
     "0143-9254",
     "0143-9255"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1743938",
     "1743941",
     "1743950",
     "1743953"
    ],
    "spl_id": [
     "67349236-e8e3-45ec-a76d-2a0a150d8d59"
    ],
    "spl_set_id": [
     "0e499952-46c7-4172-8c70-186312e240a3"
    ],
    "package_ndc": [
     "0143-9252-01",
     "0143-9252-25",
     "0143-9253-01",
     "0143-9253-25",
     "0143-9254-01",
     "0143-9254-25",
     "0143-9255-01",
     "0143-9255-25"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-7809-24",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA018826"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7809",
     "0409-7810",
     "0409-0042",
     "0409-1858"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "188ce800-ff3a-4b22-9a95-2273c3bc99ae"
    ],
    "spl_set_id": [
     "08f23f6e-150d-45ea-098e-f2edf64c21a1"
    ],
    "package_ndc": [
     "0409-7809-11",
     "0409-7809-22",
     "0409-7809-31",
     "0409-7809-24",
     "0409-7810-11",
     "0409-7810-22",
     "0409-0042-01",
     "0409-0042-12",
     "0409-1858-01",
     "0409-1858-12"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1007-02",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA019615"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE AND DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1007",
     "0338-1005",
     "0338-1009"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743869",
     "1743871",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"
    ],
    "spl_set_id": [
     "cb97d4a0-89ed-407c-a763-209386b6f75c"
    ],
    "package_ndc": [
     "0338-1005-02",
     "0338-1005-03",
     "0338-1007-02",
     "0338-1007-03",
     "0338-1009-02"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-7809-22",
   "generic_name": "Dopamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018826"
    ],
    "brand_name": [
     "DOPAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "generic_name": [
     "DOPAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7809",
     "0409-7810",
     "0409-0042",
     "0409-1858"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOPAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1292887",
     "1743877",
     "1743879"
    ],
    "spl_id": [
     "188ce800-ff3a-4b22-9a95-2273c3bc99ae"
    ],
    "spl_set_id": [
     "08f23f6e-150d-45ea-098e-f2edf64c21a1"
    ],
    "package_ndc": [
     "0409-7809-11",
     "0409-7809-22",
     "0409-7809-31",
     "0409-7809-24",
     "0409-7810-11",
     "0409-7810-22",
     "0409-0042-01",
     "0409-0042-12",
     "0409-1858-01",
     "0409-1858-12"
    ],
    "unii": [
     "7L3E358N9L"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Injection",
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "presentation": "Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22)",
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-7810-22",
   "generic_name": "Dopamine Hydrochloride Injection",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "status": "Current",
   "dosage_form": "Injection"
  }
 ]
}